We are live on ! Find out more
CH

CVI Holdings Portfolio holdings

AUM $116M
1-Year Est. Return 5.68%
This Fund
S&P 500
This Quarter Est. Return
+6.43%
1 Year Est. Return
+5.68%
3 Year Est. Return
+25.77%
5 Year Est. Return
+327.29%
10 Year Est. Return
AUM
$266M
AUM Growth
-$519M
Cap. Flow
-$520M
Cap. Flow %
-195.59%
Top 10 Hldgs %
24.71%
Holding
657
New
41
Increased
1
Reduced
224
Closed
243
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AONCW
326
DELISTED
American Oncology Network, Inc. Warrant
AONCW
$4.74K ﹤0.01%
89,339
-24,629
-22% -$1.67K
EMCGW
327
DELISTED
Embrace Change Acquisition Corp Warrants
EMCGW
$4.74K ﹤0.01%
118,500
BETRW icon
328
Better Home & Finance Warrant
BETRW
$2.2M
$4.72K ﹤0.01%
81,518
HCDIW
329
DELISTED
Harbor Custom Development, Inc. Warrant
HCDIW
$4.66K ﹤0.01%
193,402
GDSTW
330
DELISTED
Goldenstone Acquisition Limited Warrants
GDSTW
$4.59K ﹤0.01%
150,000
AEON.WS
331
DELISTED
AEON Biopharma Inc
AEON.WS
$4.33K ﹤0.01%
78,674
-28,935
-27% -$1.67K
CCTSW
332
DELISTED
Cactus Acquisition Corp. 1 Limited Warrant
CCTSW
$4.26K ﹤0.01%
77,484
-2,700
-3% -$167
PLAOW
333
DELISTED
Patria Latin American Opportunity Acquisition Corp. Warrant
PLAOW
$4.23K ﹤0.01%
46,787
-2,913
-6% -$271
VSSYW
334
DELISTED
Versus Systems Inc Class A Warrants
VSSYW
$4.2K ﹤0.01%
100,000
MTRYW
335
DELISTED
Monterey Innovation Acquisition Corp. Warrant
MTRYW
$4.17K ﹤0.01%
138,879
-59,806
-30% -$1.64K
PPYAW
336
DELISTED
Papaya Growth Opportunity Corp. I Warrant
PPYAW
$4.09K ﹤0.01%
102,404
-22,496
-18% -$1.7K
MACAW
337
DELISTED
Moringa Acquisition Corp Warrant
MACAW
$4.02K ﹤0.01%
45,024
-4,976
-10% -$558
FRLAW
338
DELISTED
Fortune Rise Acquisition Corporation Warrant
FRLAW
$3.77K ﹤0.01%
72,897
BWAQW
339
DELISTED
Blue World Acquisition Corporation Warrant
BWAQW
$3.73K ﹤0.01%
164,097
-10,903
-6% -$607
NKGNW
340
DELISTED
NKGen Biotech, Inc. Warrants
NKGNW
$3.7K ﹤0.01%
26,386
-3,614
-12% -$514
BNAIW
341
Brand Engagement Network Warrant
BNAIW
$1.97M
$3.67K ﹤0.01%
104,927
ONMDW icon
342
OneMedNet Corp Warrant
ONMDW
$1.2M
$3.65K ﹤0.01%
140,000
JGGCW
343
DELISTED
Jaguar Global Growth Corporation I Warrant
JGGCW
$3.61K ﹤0.01%
36,133
-1,361
-4% -$108
AIMAW
344
DELISTED
Aimfinity Investment Corp I Warrant
AIMAW
$3.6K ﹤0.01%
50,000
FEXDW
345
DELISTED
Fintech Ecosystem Development Corp. Warrant
FEXDW
$3.54K ﹤0.01%
100,955
VSACW
346
DELISTED
Vision Sensing Acquisition Corp. Warrants
VSACW
$3.51K ﹤0.01%
64,469
-22,610
-26% -$1.1K
MDAIW icon
347
Spectral AI Warrants
MDAIW
$5.45M
$3.49K ﹤0.01%
38,716
OCAXW
348
DELISTED
OCA Acquisition Corp. Warrant
OCAXW
$3.45K ﹤0.01%
43,671
-46,226
-51% -$3.24K
CEROW
349
DELISTED
CERo Therapeutics Warrants
CEROW
$3.26K ﹤0.01%
65,227
-7,548
-10% -$340
DISTW
350
DELISTED
Distoken Acquisition Corporation Warrant
DISTW
$3.2K ﹤0.01%
+80,000
New +$4.6K

Similar funds

CVI Holdings's Q1 2023 Portfolio in Review

As of Q1 2023, CVI Holdings held 657 positions worth $266M, down 66% from $784M the previous quarter. Its ten largest holdings account for 25% of the portfolio.

CVI Holdings withdrew a net $520M in Q1 2023, closing 243 positions and reducing 224 holdings. Its most notable exit was ImmunityBio, an estimated $38.6M position sold in full.

By sector, the portfolio is most concentrated in Financials at 68% of assets, up from 64% a quarter earlier, followed by Healthcare and Technology.

Against the trend, CVI Holdings opened a new position in GeneDx Holdings worth $3.56M.

  • CVI Holdings's largest Q1 2023 buy was GeneDx Holdings: 295,706 shares worth $3.56M.
  • CVI Holdings added most to TPG Pace Beneficial II Corp. in Q1 2023, an estimated $82.2K increase.
  • CVI Holdings's biggest Q1 2023 reduction was RTB Digital, cutting an estimated $1.96M.
  • CVI Holdings fully exited ImmunityBio in Q1 2023, selling an estimated $38.6M.
  • CVI Holdings's ten largest holdings make up 25% of its $266M portfolio in Q1 2023.
  • CVI Holdings opened 41 new positions and closed 243 in Q1 2023.
  • CVI Holdings's portfolio value fell 66% quarter-over-quarter to $266M.

Based on CVI Holdings's 13F filing for Q1 2023, filed 16 May 2023.